EndoGastric Solutions Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 82

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $105M

EndoGastric Solutions General Information

Description

Developer of a surgical technology designed for the treatment of gastroesophageal reflux disease. The company combines concepts in gastroenterology and surgery and has developed the Transoral Incisionless Fundoplication procedure which can be performed without the need for external incisions through the skin, enabling patients who require an anatomical repair, another treatment option to correct the underlying cause of GERD.

Contact Information

Formerly Known As
EsophyX
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 18109 NorthEast 76th Street
  • Suite 100
  • Redmond, WA 98052
  • United States
+1 (425)
Primary Industry
Surgical Devices
Other Industries
Therapeutic Devices
Parent Company
Vertical(s)
Corporate Office
  • 18109 NorthEast 76th Street
  • Suite 100
  • Redmond, WA 98052
  • United States
+1 (425)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EndoGastric Solutions Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
17. Merger/Acquisition 01-Jul-2024 $105M Completed Generating Revenue
16. Secondary Transaction - Private Completed Generating Revenue
15. Later Stage VC 06-Dec-2022 Completed Generating Revenue
14. Secondary Transaction - Private 24-Jun-2022 Completed Generating Revenue
13. Secondary Transaction - Private 22-Apr-2021 Completed Generating Revenue
12. Later Stage VC (Series J) 07-Dec-2020 Completed Generating Revenue
11. Debt - PPP 29-Apr-2020 Completed Generating Revenue
10. Later Stage VC (Series I) 28-May-2019 Completed Generating Revenue
9. Secondary Transaction - Private 26-Dec-2016 $153M Completed Generating Revenue
8. Later Stage VC (Series H) 26-May-2015 $10M $153M Completed Generating Revenue
To view EndoGastric Solutions’s complete valuation and funding history, request access »

EndoGastric Solutions Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series J
Series I
Series H
Series G
Series G1
Series F
Series E
Series D
Series C 6,041,662 $0.000100 $0.12 $1.47 $1.47 1x $0.91 5.73%
Series B 2,399,998 $0.000100 $0.04 $0.55 $0.55 1x $0.91 0.85%
To view EndoGastric Solutions’s complete cap table history, request access »

EndoGastric Solutions Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a surgical technology designed for the treatment of gastroesophageal reflux disease. The company combines c
Surgical Devices
Redmond, WA
82 As of 2024

Boston, MA
 

San Clemente, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

EndoGastric Solutions Competitors (6)

One of EndoGastric Solutions’s 6 competitors is Morphic Medical, a Private Equity-Backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Morphic Medical Private Equity-Backed Boston, MA
USGI Medical Venture Capital-Backed San Clemente, CA
Aspero Medical Venture Capital-Backed Boulder, CO
Mowoot Venture Capital-Backed Barcelona, Spain
Apollo Endosurgery Formerly VC-backed Austin, TX
To view EndoGastric Solutions’s complete competitors history, request access »

EndoGastric Solutions Patents

EndoGastric Solutions Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2774547-A1 Device for manipulating and fastening tissue Active 08-Mar-2013
EP-2774547-B1 Device for manipulating and fastening tissue Active 08-Mar-2013
EP-3132753-A1 Device for manipulating and fastening tissue Active 08-Mar-2013
EP-3132753-B1 Device for manipulating and fastening tissue Active 08-Mar-2013
ES-2716972-T3 Device for manipulating and fixing tissue Active 08-Mar-2013 A61B17/00234
To view EndoGastric Solutions’s complete patent history, request access »

EndoGastric Solutions Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EndoGastric Solutions Former Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
Accelmed Growth/Expansion Minority
Advanced Technology Ventures Venture Capital Minority
BCG Digital Ventures Accelerator/Incubator Minority
CRG Lender/Debt Provider Minority
Canaan Partners Venture Capital Minority
You’re viewing 5 of 17 investors. Get the full list »

EndoGastric Solutions FAQs

  • When was EndoGastric Solutions founded?

    EndoGastric Solutions was founded in 2002.

  • Where is EndoGastric Solutions headquartered?

    EndoGastric Solutions is headquartered in Redmond, WA.

  • What is the size of EndoGastric Solutions?

    EndoGastric Solutions has 82 total employees.

  • What industry is EndoGastric Solutions in?

    EndoGastric Solutions’s primary industry is Surgical Devices.

  • Is EndoGastric Solutions a private or public company?

    EndoGastric Solutions is a Private company.

  • What is the current valuation of EndoGastric Solutions?

    The current valuation of EndoGastric Solutions is .

  • What is EndoGastric Solutions’s current revenue?

    The current revenue for EndoGastric Solutions is .

  • How much funding has EndoGastric Solutions raised over time?

    EndoGastric Solutions has raised $243M.

  • Who are EndoGastric Solutions’s investors?

    Accelmed, Advanced Technology Ventures, BCG Digital Ventures, CRG, and Canaan Partners are 5 of 17 investors who have invested in EndoGastric Solutions.

  • Who are EndoGastric Solutions’s competitors?

    Morphic Medical, USGI Medical, Aspero Medical, Mowoot, and Apollo Endosurgery are some of the 6 competitors of EndoGastric Solutions.

  • When was EndoGastric Solutions acquired?

    EndoGastric Solutions was acquired on 01-Jul-2024.

  • Who acquired EndoGastric Solutions?

    EndoGastric Solutions was acquired by Merit Medical Systems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process